Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
4(15%)
Results Posted
17%(2 trials)

Phase Distribution

Ph early_phase_1
2
7%
Ph phase_1
1
4%
Ph phase_3
1
4%
Ph phase_2
2
7%
Ph not_applicable
6
22%
Ph phase_4
12
44%

Phase Distribution

3

Early Stage

2

Mid Stage

13

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
2(8.3%)
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
2(8.3%)
Phase 3Large-scale testing
1(4.2%)
Phase 4Post-market surveillance
12(50.0%)
N/ANon-phased studies
6(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

4

trials recruiting

Total Trials

27

all time

Status Distribution
Active(5)
Completed(12)
Terminated(2)
Other(8)

Detailed Status

Completed12
unknown8
Recruiting4
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.3%)
Phase 11 (4.2%)
Phase 22 (8.3%)
Phase 31 (4.2%)
Phase 412 (50.0%)
N/A6 (25.0%)

Trials by Status

completed1244%
recruiting415%
withdrawn27%
unknown830%
not_yet_recruiting14%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07492134Phase 2

APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)

Not Yet Recruiting
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting
NCT05784311Phase 4

Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)

Recruiting
NCT06527560Phase 4

Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with Pyelonephritis

Recruiting
NCT05609240Phase 2

Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery

Recruiting
NCT04303390Phase 4

24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis

Completed
NCT04479657Early Phase 1

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

Unknown
NCT04470973

Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.

Unknown
NCT05388747

Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates

Unknown
NCT04212078Phase 1

Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime

Unknown
NCT02789579Early Phase 1

The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy

Unknown
NCT01659866Phase 4

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

Completed
NCT02850250

Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery

Withdrawn
NCT00497341Phase 4

Antibiotic Prophylaxis in Total Knee Prosthesis

Completed
NCT00136344Not Applicable

Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery

Completed
NCT02009098Phase 4

RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section

Withdrawn
NCT02072798Phase 4

Antibiotics and Gut Microbiota Among Newborn Infants

Completed
NCT00901628Phase 4

Periarticular Multimodal Drug Injections in Total Knee Arthroplasty

Completed
NCT01080963Phase 4

Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections

Completed
NCT01372371Not Applicable

Efficacy of Local Powder Prophylactics

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
27